ixazomib
"
イザゾミブシトラート (1201902-80-8)
Ixazomib Citrate (1201902-80-8) Ixazomib citrate is a proteasome inhibitor that prevents cell growth in solid tumours. This anti-cancer agent is specifically used for the treatment of multiple myeloma. Compared with bortezomib, Ixazomib citrate demonstrates superior pharmacokinetics, efficacy, and ...
2-(2,5-ディクロロベンザミド) 乙酸 (667403-46-5)
2-(2,5-dichlorobenzamido)acetic acid (667403-46-5) 2-(2,5-dichlorobenzamido)acetic acid is a chemical compound used in the preparation of Ixazomib, a pharmaceutical intermediate. This compound serves as a key intermediate in pharmaceutical synthesis, specifically for the production of Ixazomib. ...
(αR) - (((1S,2S,3R,5S) -ピナナディオール-1-アミノ-3-メチルブタン-1-ボロナートトリフルーアセタート (179324-87-9)
(αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetate (179324-87-9) (αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetate (179324-87-9) is a specialized chemical compound used in the design and preparation of pharmaceutical agents including ...
